Antitumor activities of human dendritic cells derived from peripheral and cord blood.
Explore this paper's citation graph
Summary
Peripheral blood DC and cord blood DC are mature DC in morphology and function, both can enhance the effector cell killing activities to hepatocarcinoma cells.
- Type
- article
- Published
- 2002-02-15
- Cited by
- 18
- References
- 50
- Access
- Open access
- OpenAlex
- https://openalex.org/W1454688
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:41944974
Keywords
Cord blood, Effector, Dendritic cell, Immunology, CTL*
References
- Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells.
- Influence of granulocyte macrophage colony stimulating factor and tumor necrosis factor on anti-hepatoma activities of human dendritic cells.
- Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients.
- Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
- Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
- T Cells and Dendritic Cells Get Intimate
- Migration of human dendritic cells after injection in patients with metastatic malignancies.
- Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals.
- Dendritic cells and the control of immunity
- Type I IFNs enhance the terminal differentiation of dendritic cells.
- Dendritic cells directly modulate B cell growth and differentiation
- Advances in cancer vaccine development.
- Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response
- Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte–macrophage colony‐stimulating factor genetically modified dendritic cells
- Dendritic Cells Promote T-cell Survival or Death Depending Upon Their Maturation State and Presentation of Antigen
- The control of T cell responses by dendritic cell subsets.
- From synapses to immunological memory: the role of sustained T cell stimulation.
- Dendritic cell–B‐cell interaction: dendritic cells provide B cells with CD40‐independent proliferation signals and CD40‐dependent survival signals
- Experimental vaccine strategies for cancer immunotherapy.
- Idiotypic protein‐pulsed dendritic cell vaccination in multiple myeloma
Cited by
- DC-SIGN: binding receptor for HCV?
- Functional changes of dendritic cells derived from allogeneic partial liver graft undergoing acute rejection in rats.
- Study on immune function of dendritic cells in patients with esophageal carcinoma.
- Dendritic cells and hepatocellular carcinoma.
- Dendritic cell-based immunotherapy: A promising approach for treatment of cancer
- Morphological observation of tumor infiltrating immunocytes in human rectal cancer.
- Production of functional dendritic cells from menstrual blood—a new dendritic cell source for immune therapy
- Killer dendritic cells: IKDC and the others.
- Dendritic cell vaccination
- Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.
- Role of dendritic cells in progression and clinical outcome of colon cancer
- Expression and Distribution of S-100, CD83, and Costimulatory Molecules (CD80 and CD86) in Tissues of Thyroid Papillary Carcinoma
- Expression and distribution of S-100, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in tissues of thyroid carcinoma.
- Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer.
- NF-kappaB activation and zinc finger protein A20 expression in mature dendritic cells derived from liver allografts undergoing acute rejection.
- Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo.
- Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot study.
- Dendritic cells and hepatocellular carcinoma
Related papers
- IL-15 stimulates the expansion of AIDS virus-specific CTL.
- Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity
- Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815
- The functional transformation of cytotoxic lymphocytes into T-suppressors under the influence of two mediators.
- Broad CTL Response in Early HIV Infection Drives Multiple Concurrent CTL Escapes
- Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes.
- Creatol, a creatinine metabolite, as a useful determinant of renal function.
- 自身肽结合于HLA-A2分子上能够在体外诱导抗原肽特异性的同种T细胞
- CD1c(+) immature myeloid dendritic cells are predominant in cord blood of healthy neonates.